期刊文献+

应用肥胖国际功能、失能和健康分类综合核心组合描述肥胖型多囊卵巢综合征的疾病特征 被引量:7

Disease characteristics of obese patients with polycystic ovary syndrome described by the obesity component of the International Classification of Functioning, Disability and Health comprehensive core set
原文传递
导出
摘要 目的 使用肥胖ICF综合核心组合对肥胖型多囊卵巢综合征(PCOS)的疾病特征进行描述,揭示和探讨符合肥胖型PCOS疾病特征功能障碍的相关领域.方法 使用肥胖ICF综合核心组合对60例肥胖型PCOS患者进行评估,大于30%的患者报告作为障碍的条目才被考虑与PCOS患者的功能相关.结果 参与研究的60例肥胖型PCOS患者中,肥胖ICF综合核心组合条目的109条中有20个条目被选择与PCOS疾病特征相关.其中,身体功能领域有6条(占全部被选择条目的30%),身体结构领域有1条(占全部被选择条目的5%),环境因素领域有13条(占全部被选择条目的65%).结论 肥胖ICF综合核心组合可用于描述肥胖型PCOS的疾病特征和功能障碍,为临床应用ICF核心组合评估PCOS患者的功能障碍提供了可能. Objective To describe the disease characteristics of obese patients with polycystic ovary syndrome (PCOS) using the obesity core set of the obesity International Classification of Functioning,Disability and Health (ICF) to reveal the related dysfunction domains.Methods Sixty obese patients with PCOS were evaluated by using the ICF's obesity comprehensive core set.Categories reported as a problem by at least 30% of the patients were considered as a relevant functional profile for PCOS patients.Results In obese 60 patients with PCOS,20 items were selected from 109 items of obesity ICF comprehensive core set and considered as the relevant functional characteristics for PCOS among the obese,in which 6 items of body functions (30% of all selected items),1 item of body structures (5% of all selected items),and 13 items of environmental factors (65% of all selected items) were included.Conclusions The obesity core set of the ICF can be applied to describe the disease characteristics and dysfunction of obese patients with PCOS,which offers the possibility of clinic application of the ICF core set for PCOS.
出处 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2015年第1期20-23,共4页 Chinese Journal of Physical Medicine and Rehabilitation
基金 江苏省社会发展支撑计划(BE2009613)
关键词 肥胖 国际功能、残疾和健康分类 多囊卵巢综合征 Obesity International Classification of Functioning,Disability and Health Polycystic ovary syndrome
  • 相关文献

参考文献14

  • 1Moran L, Pasquali R,Teede H J, et al. Treatment of obesity in polycystic ovary syndrome:a position statement of the androgen excess and poly- cystic ovary syndrome society [ J ]. Fertil Steril, 2009,92 ( 6 ) : 1966- 1982.
  • 2Stucki A, Borchers M, Stueki G, et al. Content comparison of health sta- tus measures for obesity based on the international classification of functioning, disability and health [ J ]. Int J Obes,2006,30 ( 12 ) : 1791 - 1799.
  • 3Norman R J, Dewailly D, Legro RS, et al. Polycystic ovary syndrome [J]. Lancet,2007,370(9588) :685-697.
  • 4邱卓英,王朴,王博.《国际功能、残疾和健康分类》的发展和应用进展[J].中国康复理论与实践,2008,14(1):85-86. 被引量:45
  • 5Lin YN, Chang KH, Lin CY,et al. Developing comprehensive and Brief ICF core sets for morbid obesity for disability assessment in Taiwan: a preliminary study[ J ]. Eur J Phys Rehabil Med, 2014,50 ( 2 ) : 133- 141.
  • 6Karimzadeh MA, Javedani M. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin and clo- miphene citrate-mefformin in patients with polycystic ovary syndrome [ J]. Fertil Steril,2010,94( 1 ) :216-220.
  • 7李翔,王茂斌.《国际功能分类》概览[J].国外医学(脑血管疾病分册),2003,11(5):340-344. 被引量:5
  • 8Ding X, Reimann S,Timrott K, et al. Comparison of the ICF core set for cardiopulmonary conditions in the acute hospital setting among different types of transplant patients[ J]. Int J Rehabil Res,2010,33 (4) :325- 331.
  • 9刘杰,江钟立.中国人群原发性骨质疏松症简明ICF核心组套的初步研究[J].中国骨质疏松杂志,2012,18(9):803-807. 被引量:10
  • 10Raggi A, Sirtori A, Brunani A, et al. Use of the ICF to describe functio- ning and disability in obese patients [ J ]. Disabil Rehabil, 2009,31 (S1) : S153-S158.

二级参考文献69

  • 1贺丹军,江钟立,李勇,刘莉莉,吴玉琴.慢性疲劳综合征患者生活方式的特征[J].中国行为医学科学,2006,15(8):689-691. 被引量:6
  • 2联合国残疾人权利公约[J].中国康复理论与实践,2007,13(2):101-108. 被引量:25
  • 3邱卓英,荀芳,张爱民.世界卫生组织残疾与康复行动计划(2006年~2011年)[J].中国康复理论与实践,2007,13(2):109-110. 被引量:15
  • 4邱卓英,李建军.国际社会有关残疾与康复的理念和发展战略的研究[J].中国康复理论与实践,2007,13(2):111-113. 被引量:48
  • 5世界卫生组织.国际功能分类:中文版[M].日内瓦:世界卫生组织,2001..
  • 6世界卫生组织.国际功能残疾和健康分类 .终级版草案:中文版[M].日内瓦:世界卫生组织,2000..
  • 7Moran L,Pasquali R,Teede HJ,et al.Treatment of obesity in polycystic ovary syndrome:a position statement of the androgen excess and polycystic ovary syndrome society.Fertil Steril,2009,92:1966-1982.
  • 8Karimzadeh M,Javedani M.An assessment of lifestyle modification versus medical treatment with clomiphene citrate,metformin and clomiphene eitrate-metformin in patients with polycystic ovary syndrome.Fertil Steril,2010,94:216-20.
  • 9王桂茹,马唯,翁静.不孕症//史小林.人类生殖学.北京:科学出版社,2002:277.
  • 10Jones J,Barry M.Developing a.scale to measure synergy in health promotion partnerships.Gloh Health Promot,2011,18:36-44.

共引文献90

同被引文献45

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部